Science Explorer Interactive view Map
Company · Dundee · United Kingdom

Cyclacel Pharmaceuticals (United Kingdom)

cyclacel.comROR OpenAlex
Research works
94
▼ 35% vs 2013–17
Citations
4.1k
43.5 per fractional work
Top-10% rate
20.0%
record average 16.5%
Open access
22%
world 28%

Not ranked overall: Cyclacel Pharmaceuticals (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Cyclacel Pharmaceuticals (United Kingdom)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Mutation, Apoptosis, Tumor Suppression, Cell Cycle, p53, Metastatic Breast Cancer and Breast Cancer.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Therapy30▲ 51×9 topics
  2. Apoptosis17▲ 46×2 topics
  3. Mutation17▲ 114×2 topics
  4. Tumor Suppression16▲ 152×2 topics
  5. Cell Cycle16▲ 300×1 topic
  6. p5316▲ 397×1 topic
  7. Metastatic Breast Cancer11▲ 174×2 topics
  8. Breast Cancer10▲ 39×4 topics
  9. Cell Cycle Control10▲ 405×2 topics
  10. CDK4/6 Inhibitors9▲ 633×1 topic
  11. Palbociclib9▲ 633×1 topic
  12. Cell Division8▲ 234×1 topic
  13. Microtubules8▲ 234×1 topic
  14. Prognostic Factors7▲ 16×4 topics
  15. Drug Discovery6▲ 15×5 topics
  16. Cancer4▲ 3.1×11 topics
  17. Chemotherapy4▲ 5.9×9 topics
  18. Rituximab4▲ 25×2 topics
  19. Therapeutic Targets4▲ 17×3 topics
  20. Proteasome Inhibitors3▲ 50×2 topics
  21. Transcriptional Regulation3▲ 14×3 topics
  22. Chronic Lymphocytic Leukemia3▲ 71×1 topic
  23. Genomic Aberrations3▲ 71×1 topic
  24. Proteasome3▲ 79×1 topic
  25. Ubiquitin3▲ 79×1 topic
  26. BET Bromodomains3▲ 143×1 topic
  27. Gene Therapy3▲ 11×3 topics
  28. PROTACs3▲ 143×1 topic
  29. Foldamers3▲ 34×1 topic
  30. Homologous Recombination3▲ 42×2 topics
  31. Peptide Synthesis3▲ 34×1 topic
  32. Protein-Protein Interactions3▲ 26×2 topics
  33. Tumor Microenvironment3▲ 7.9×3 topics
  34. Cancer Progression2▲ 11×3 topics
  35. Tumor Hypoxia2▲ 29×2 topics
  36. AML2▲ 53×1 topic
  37. Acute Myeloid Leukemia2▲ 53×1 topic
  38. Molecular Docking2▲ 18×3 topics
  39. Genomic Stability2▲ 24×2 topics
  40. Inhibitors2▲ 32×2 topics

Which research topics does Cyclacel Pharmaceuticals (United Kingdom) publish most on?

By volume in 2022–2025: Chronic Lymphocytic Leukemia Research, Advanced Breast Cancer Therapies, Cancer-related Molecular Pathways and CAR-T cell therapy research.

Chronic Lymphocytic Leuk…1Chronic Lymphocytic Leukemia Research: 1 fractional worksAdvanced Breast Cancer T…1Advanced Breast Cancer Therapies: 1 fractional worksCancer-related Molecular Pathways: 0 fractional worksCAR-T cell therapy research: 0 fractional worksT-cell and Retrovirus Studies: 0 fractional worksCancer Treatment and Pharmacology: 0 fractional worksCancer, Lipids, and Metabolism: 0 fractional worksColorectal Cancer Treatments and Studies: 0 fractional worksCancer Cells and Metastasis: 0 fractional works
GeneticsPulmonary and Respiratory MedicineOncologyImmunology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Chronic Lymphocytic Leukemia Research Genetics 1 works
  2. 2 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  3. 3 Cancer-related Molecular Pathways Oncology 0 works
  4. 4 CAR-T cell therapy research Oncology 0 works
  5. 5 T-cell and Retrovirus Studies Immunology 0 works
  6. 6 Cancer Treatment and Pharmacology Oncology 0 works
  7. 7 Cancer, Lipids, and Metabolism Cancer Research 0 works
  8. 8 Colorectal Cancer Treatments and Studies Oncology 0 works
  9. 9 Cancer Cells and Metastasis Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available22.4%not open77.6%

World: 28% of research is openly available.

with international co-authors20.3%domestic only79.7%

World: 19% is written across borders.

How has Cyclacel Pharmaceuticals (United Kingdom)'s research output changed?

Output in 2018–2022 was 35% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Dundee

All research institutions in Dundee

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.